Please enable JavaScript to continue using this application.

Compare $PLX vs $SION | Chartloom

Compare

$PLX vs $SION

Protalix Biotherapeutics Inc · Sionna Therapeutics Inc

PLX

Protalix Biotherapeutics Inc

SION

Sionna Therapeutics Inc

Compare $PLX vs $SION

Comparing Protalix Biotherapeutics Inc and Sionna Therapeutics Inc

PLXProtalix Biotherapeutics Inc

SIONSionna Therapeutics Inc

PLXProtalix Biotherapeutics Inc

Market cap

$224M

P/E (TTM)

12.11x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.56x

Rev growth (TTM)

30.1%

YTD performance

59.8%

52W performance

8.2%

FCF yield

3.4%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PLX

SION

Detailed metrics comparison

PLX

Protalix Biotherapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

PLX$224M

SION$221M

Enterprise Value

PLX$197M

SION$158M

Price

PLX$2.78

SION$4.90

P/E Ratio

PLX12.11x

SIONN/A

P/S Ratio

PLX2.78x

SION0.00x

EV/Sales

PLX2.44x

SION0.00x

EV/EBITDA

PLX7.37x

SION0.00x

P/B Ratio

PLX3.06x

SION0.84x

P/FCF Ratio

PLX29.21x

SIONN/A

EV/FCF

PLX25.63x

SION-2.07x

PEG Ratio

PLX0.06x

SIONN/A

Forward P/E (NTM)

PLXN/A

SIONN/A

Forward P/S (NTM)

PLX3.56x

SIONN/A

Revenue (TTM)

PLX$81M

SION$0

Revenue Growth (YoY)

PLX30.1%

SIONN/A

Forward Rev Growth

PLX-19.1%

SION1297.1%

Gross Margin (TTM)

PLX69.2%

SION0.0%

Operating Margin (TTM)

PLX28.9%

SION0.0%

EBITDA Margin (TTM)

PLX30.8%

SION0.0%

Net Margin (TTM)

PLX23.5%

SION0.0%

FCF Margin (TTM)

PLX9.5%

SIONN/A

Net Income (TTM)

PLX$19M

SION$-97M

FCF (TTM)

PLX$8M

SION$-76M

EPS (TTM)

PLX$0.23

SION-$2.16

ROE (TTM)

PLX31.6%

SION-3294.0%

ROA (TTM)

PLX20.1%

SION-3108.0%

ROIC (TTM)

PLX31.6%

SION-3294.0%

Cash

PLX$27M

SION$63M

Debt

PLX$0

SION$0

Net Cash/Debt

PLX$27M

SION$63M

Current Ratio (TTM)

PLX2.94x

SION20.05x

Quick Ratio (TTM)

PLX1.91x

SION19.57x

Debt/Equity (TTM)

PLX0.00x

SION0.00x

Debt/Assets (TTM)

PLX0.0%

SION0.0%

Interest Coverage (TTM)

PLXN/A

SIONN/A

Net Debt/EBITDA (TTM)

PLX0.00x

SION0.00x

Beta

PLX-0.05

SION1.44

52W Performance

PLX8.2%

SION-82.8%

YTD Performance

PLX59.8%

SION-87.5%

% from 52W High

PLX-12.9%

SION-91.1%

% from 52W Low

PLX73.7%

SION22.2%

Asset Turnover (TTM)

PLX0.85x

SION0.00x

FCF Yield (TTM)

PLX3.4%

SION-34.4%

Earnings Yield (TTM)

PLX8.5%

SION-44.0%

Dividend Yield (TTM)

PLXN/A

SIONN/A

Rule of 40

PLX39.7

SION0.0

EV/GP/RG

PLXN/A

SIONN/A

Ticker research

View PLX research View SION research

Metric	PLX Protalix Biotherapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$224M	$221M
Enterprise Value	$197M	$158M
Price	$2.78	$4.90
P/E Ratio	12.11x	N/A
P/S Ratio	2.78x	0.00x
EV/Sales	2.44x	0.00x
EV/EBITDA	7.37x	0.00x
P/B Ratio	3.06x	0.84x
P/FCF Ratio	29.21x	N/A
EV/FCF	25.63x	-2.07x
PEG Ratio	0.06x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.56x	N/A
Revenue & Growth
Revenue (TTM)	$81M	$0
Revenue Growth (YoY)	30.1%	N/A
Forward Rev Growth	-19.1%	1297.1%
Profitability
Gross Margin (TTM)	69.2%	0.0%
Operating Margin (TTM)	28.9%	0.0%
EBITDA Margin (TTM)	30.8%	0.0%
Net Margin (TTM)	23.5%	0.0%
FCF Margin (TTM)	9.5%	N/A
Net Income (TTM)	$19M	$-97M
FCF (TTM)	$8M	$-76M
EPS (TTM)	$0.23	-$2.16
ROE (TTM)	31.6%	-3294.0%
ROA (TTM)	20.1%	-3108.0%
ROIC (TTM)	31.6%	-3294.0%
Financial Health
Cash	$27M	$63M
Debt	$0	$0
Net Cash/Debt	$27M	$63M
Current Ratio (TTM)	2.94x	20.05x
Quick Ratio (TTM)	1.91x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.05	1.44
52W Performance	8.2%	-82.8%
YTD Performance	59.8%	-87.5%
% from 52W High	-12.9%	-91.1%
% from 52W Low	73.7%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	3.4%	-34.4%
Earnings Yield (TTM)	8.5%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	39.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PLX research	View SION research

Valuation

P/E Ratio

PLX

12.11x

P/S Ratio

SION

0.00x

PLX

2.78x

EV/FCF

SION

-2.07x

PLX

25.63x

Growth & revenue

Revenue Growth TTM

PLX

30.1%

Forward Revenue Growth

SION

1297.1%

PLX

-19.1%

Profitability & performance

Gross Margin

PLX

69.2%

SION

0.0%

ROE

PLX

31.6%

SION

-3294.0%

FCF Yield %

PLX

3.4%

SION

-34.4%

52-Week Performance

PLX

8.2%

SION

-82.8%

Detailed metrics comparison

PLX

Protalix Biotherapeutics Inc

SION

Sionna Therapeutics Inc

Market Cap

PLX$224M

SION$221M

Enterprise Value

PLX$197M

SION$158M

Price

PLX$2.78

SION$4.90

P/E Ratio

PLX12.11x

SIONN/A

P/S Ratio

PLX2.78x

SION0.00x

EV/Sales

PLX2.44x

SION0.00x

EV/EBITDA

PLX7.37x

SION0.00x

P/B Ratio

PLX3.06x

SION0.84x

P/FCF Ratio

PLX29.21x

SIONN/A

EV/FCF

PLX25.63x

SION-2.07x

PEG Ratio

PLX0.06x

SIONN/A

Forward P/E (NTM)

PLXN/A

SIONN/A

Forward P/S (NTM)

PLX3.56x

SIONN/A

Revenue (TTM)

PLX$81M

SION$0

Revenue Growth (YoY)

PLX30.1%

SIONN/A

Forward Rev Growth

PLX-19.1%

SION1297.1%

Gross Margin (TTM)

PLX69.2%

SION0.0%

Operating Margin (TTM)

PLX28.9%

SION0.0%

EBITDA Margin (TTM)

PLX30.8%

SION0.0%

Net Margin (TTM)

PLX23.5%

SION0.0%

FCF Margin (TTM)

PLX9.5%

SIONN/A

Net Income (TTM)

PLX$19M

SION$-97M

FCF (TTM)

PLX$8M

SION$-76M

EPS (TTM)

PLX$0.23

SION-$2.16

ROE (TTM)

PLX31.6%

SION-3294.0%

ROA (TTM)

PLX20.1%

SION-3108.0%

ROIC (TTM)

PLX31.6%

SION-3294.0%

Cash

PLX$27M

SION$63M

Debt

PLX$0

SION$0

Net Cash/Debt

PLX$27M

SION$63M

Current Ratio (TTM)

PLX2.94x

SION20.05x

Quick Ratio (TTM)

PLX1.91x

SION19.57x

Debt/Equity (TTM)

PLX0.00x

SION0.00x

Debt/Assets (TTM)

PLX0.0%

SION0.0%

Interest Coverage (TTM)

PLXN/A

SIONN/A

Net Debt/EBITDA (TTM)

PLX0.00x

SION0.00x

Beta

PLX-0.05

SION1.44

52W Performance

PLX8.2%

SION-82.8%

YTD Performance

PLX59.8%

SION-87.5%

% from 52W High

PLX-12.9%

SION-91.1%

% from 52W Low

PLX73.7%

SION22.2%

Asset Turnover (TTM)

PLX0.85x

SION0.00x

FCF Yield (TTM)

PLX3.4%

SION-34.4%

Earnings Yield (TTM)

PLX8.5%

SION-44.0%

Dividend Yield (TTM)

PLXN/A

SIONN/A

Rule of 40

PLX39.7

SION0.0

EV/GP/RG

PLXN/A

SIONN/A

Ticker research

View PLX research View SION research

Metric	PLX Protalix Biotherapeutics Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$224M	$221M
Enterprise Value	$197M	$158M
Price	$2.78	$4.90
P/E Ratio	12.11x	N/A
P/S Ratio	2.78x	0.00x
EV/Sales	2.44x	0.00x
EV/EBITDA	7.37x	0.00x
P/B Ratio	3.06x	0.84x
P/FCF Ratio	29.21x	N/A
EV/FCF	25.63x	-2.07x
PEG Ratio	0.06x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.56x	N/A
Revenue & Growth
Revenue (TTM)	$81M	$0
Revenue Growth (YoY)	30.1%	N/A
Forward Rev Growth	-19.1%	1297.1%
Profitability
Gross Margin (TTM)	69.2%	0.0%
Operating Margin (TTM)	28.9%	0.0%
EBITDA Margin (TTM)	30.8%	0.0%
Net Margin (TTM)	23.5%	0.0%
FCF Margin (TTM)	9.5%	N/A
Net Income (TTM)	$19M	$-97M
FCF (TTM)	$8M	$-76M
EPS (TTM)	$0.23	-$2.16
ROE (TTM)	31.6%	-3294.0%
ROA (TTM)	20.1%	-3108.0%
ROIC (TTM)	31.6%	-3294.0%
Financial Health
Cash	$27M	$63M
Debt	$0	$0
Net Cash/Debt	$27M	$63M
Current Ratio (TTM)	2.94x	20.05x
Quick Ratio (TTM)	1.91x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.05	1.44
52W Performance	8.2%	-82.8%
YTD Performance	59.8%	-87.5%
% from 52W High	-12.9%	-91.1%
% from 52W Low	73.7%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	3.4%	-34.4%
Earnings Yield (TTM)	8.5%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	39.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PLX research	View SION research